Changes of serum dipeptidy1 peptidase-4 and oxidized low-density lipoprotein levels in type 2 diabetic patients with carotid atherosclerosis

被引：0
|
作者：
钟玉梅 [1 ]
机构：
[1] Endocrinol,2nd People′s Hosp
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2022年 / 39卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R587.2 [糖尿病性昏迷及其他并发症]; R743.3 [急性脑血管疾病（中风）];
学科分类号：
摘要：
Objective To explore the changes of serum dipeptidyl peptidase-4 (DPP-4) and oxidized low-density lipoprotein) ox-LDL) levels in patients with T2DM combined with carotid atherosclerosis (CAS).Methods A retrospective analysis of 120 T2DM patients in the Department of Endocrinology, Second People′s Hospital of Yichang city from January 2020 to October 2020 was conducted. All the included T2DM patients underwent carotid artery color Doppler ultrasound examination, and carotid artery intima was obtained by carotid ultrasound.
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [41] Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine
    Yildirim, Serap
    Akar, Sedat
    Kuyucu, Mutlu
    Yildirim, Abdulkadir
    Dane, Senol
    Aygul, Recep
    CELL BIOCHEMISTRY AND FUNCTION, 2011, 29 (07) : 549 - 554
  • [42] A low-grade increase of serum pancreatic exocrine enzyme levels by dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes
    Tokuyama, Hirotake
    Kawamura, Harukiyo
    Fujimoto, Masaki
    Kobayashi, Kazuki
    Nieda, Mie
    Okazawa, Tetsuya
    Takemoto, Minoru
    Shimada, Fumio
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 (03) : E66 - E69
  • [43] Increased Expression and Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Patients With Aortic Valve Stenosis
    Yoshiyama, Tomotaka
    Yunoki, Kei
    Komatsu, Ryushi
    Haze, Kazuo
    Naruko, Takahiko
    Sugioka, Kenichi
    Nakagawa, Masashi
    Inaba, Mayumi
    Yoshiyama, Minoru
    Uchida, Kagehiro
    Sawamura, Tatsuya
    Ueda, Makiko
    CIRCULATION, 2014, 130
  • [44] Glibenclamide improves postprandial hypertriglyceridaemia in Type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels
    Skrapari, I
    Perrea, D
    Ioannidis, I
    Karabina, SAP
    Elisaf, M
    Tselepis, AD
    Karagiannacos, P
    Katsilambros, N
    DIABETIC MEDICINE, 2001, 18 (10) : 781 - 785
  • [45] Association of oxidized low-density lipoprotein and transforming growth factor-beta in type 2 diabetic patients; a cross-sectional study
    Nakhjavani, Manouchehr
    Esteghamati, Alireza
    Asgarani, Firouzeh
    Khalilzadeh, Omid
    Nikzamir, Abdolrahim
    Safari, Reza
    TRANSLATIONAL RESEARCH, 2009, 153 (02) : 86 - 90
  • [46] Oxidized low-density lipoprotein/β2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus
    Lopez, LR
    Hurley, BL
    Simpson, DF
    Matsuura, E
    AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 97 - 103
  • [47] Circulating oxidized low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: The atherosclerosis risk in communities study
    Hoogeveen, RC
    Ballantyne, CM
    Bang, HJ
    Duncan, BB
    Folsom, AR
    Pankow, JS
    CIRCULATION, 2005, 112 (17) : U853 - U853
  • [48] Circulating Oxidized Low-Density Lipoprotein Levels Independently Predict 10-Year Progression of Subclinical Carotid Atherosclerosis: A Community-Based Cohort Study
    Gao, Shen
    Zhao, Dong
    Qi, Yue
    Wang, Wei
    Wang, Miao
    Sun, Jiayi
    Liu, Jun
    Li, Yan
    Liu, Jing
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (10) : 1032 - 1043
  • [49] Serum oxidized low density lipoprotein serves as a mediator for the inverse relationship between serum D-ribose and cognitive performance in type 2 diabetic patients
    Lu, Yanhui
    Jiang, Hua
    Zhang, Huijing
    Li, Ruxue
    Zhang, Qi
    Luo, Dan
    Cai, Xue
    Li, Mingzi
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 171 : 91 - 98
  • [50] Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results
    Vavere, Andrea L.
    Sinsakul, Marvin
    Ongstad, Emily L.
    Yang, Ye
    Varma, Vijayalakshmi
    Jones, Christopher
    Goodman, Joanne
    Dubois, Vincent F.
    Quartino, Angelica L.
    Karathanasis, Sotirios K.
    Abuhatzira, Liron
    Collen, Anna
    Antoniades, Charalambos
    Koren, Michael J.
    Gupta, Ruchi
    George, Richard T.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (03):
12345